ESR1 and breast carcinoma: In ERα positive breast cancer cells, estradiol can bind ERα and activate its canonical signaling pathway, in which ERα acts as a nuclear transcription factor or cofactor, modulating the expression of its target genes in a manner that promotes cell proliferation and growth.